8-KExhibits & Filings

JPMORGAN CHASE & CO 8-K Report, Exhibit Filing (May 22, 2007)

Filed May 22, 2007For Securities:JPMJPM-PCJPM-PDJPM-PKJPM-PLJPM-PMJPM-PJAMJBVYLD

Summary

This Form 8-K filing by JPMORGAN CHASE & CO. (JPM) from May 2007 primarily serves as an update on exhibits related to various structured financial products. Specifically, it incorporates by reference tax opinions from Davis Polk & Wardwell for several series of notes, including Buffered Return Enhanced Notes, Lesser Index Annual Review Notes, Return Enhanced Notes, and Reverse Exchangeable Notes. These notes are linked to diverse underlying assets such as international stock indices (AMEX Hong Kong 30, FTSE/Xinhua China 25, Korea Stock Price Index 200, MSCI Taiwan, MSCI Singapore, Dow Jones EURO STOXX 50, Nikkei 225, MSCI EAFE) and the common stock of Amgen Inc. For investors, this filing highlights the company's ongoing issuance of complex financial instruments. The inclusion of tax opinions suggests these products are being offered to clients, underscoring JPM's role in providing structured investment solutions. While the filing itself does not contain new financial results or operational updates, it points to the breadth of JPM's product offerings and its engagement with the capital markets through these derivative-like securities.

Key Highlights

  • 1Filing primarily consists of exhibit information related to structured financial products.
  • 2Includes tax opinions from Davis Polk & Wardwell for various note issuances.
  • 3Notes are linked to a diverse range of international stock indices and individual company stock.
  • 4Specific note types mentioned include Buffered Return Enhanced Notes, Lesser Index Annual Review Notes, Return Enhanced Notes, and Reverse Exchangeable Notes.
  • 5Maturity dates for these notes range from May 2008 to November 2008.
  • 6The filing is an "Associated Document" incorporated by reference into a Form S-3ASR registration statement.

Frequently Asked Questions

The primary purpose of this 8-K filing is to report and incorporate by reference various exhibits, specifically tax opinions from Davis Polk & Wardwell, related to several series of structured notes issued by JPMORGAN CHASE & CO. It does not contain new financial statements or operational updates.

The filing references several types of structured notes, including Buffered Return Enhanced Notes, Lesser Index Annual Review Notes, Return Enhanced Notes, and 9.00% Reverse Exchangeable Notes. These notes are linked to various international stock market indices and the common stock of Amgen Inc.

The inclusion of tax opinions from a reputable law firm like Davis Polk & Wardwell indicates that JPMORGAN CHASE & CO. is providing these structured products to investors, and the tax opinions offer guidance on the tax treatment of these investments. This is a common practice for complex financial instruments.

No, this particular 8-K filing does not provide any new financial performance data or operational updates for JPMORGAN CHASE & CO. Its content is limited to exhibit information regarding structured financial products.